• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Barriers to initial COVID-19 booster among US adults who completed a primary vaccine series in the CHASING COVID cohort, September 2021-October 2022.2021年9月至2022年10月在“追踪新冠”队列中完成初级疫苗接种系列的美国成年人首次接种新冠加强针的障碍
Am J Epidemiol. 2025 May 7;194(5):1341-1351. doi: 10.1093/aje/kwae209.
2
Time to COVID-19 Vaccination by Language and Country of Origin.接种 COVID-19 疫苗的时间按语言和原籍国划分。
JAMA Netw Open. 2024 Oct 1;7(10):e2437388. doi: 10.1001/jamanetworkopen.2024.37388.
3
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study.自加强疫苗接种以来的时间与新冠病毒相关哮喘加重的新冠病毒疾病严重程度及风险:来自英国COVIDENCE研究数据的纵向分析
BMJ Open Respir Res. 2025 May 15;12(1):e003158. doi: 10.1136/bmjresp-2025-003158.
4
COVID-19 Booster Uptake: Are Hesitant Adopters Less Likely to Get a Booster Shot Than Nonhesitant Adopters?新冠病毒加强针接种情况:犹豫不决的接种者比不犹豫的接种者更不可能接种加强针吗?
Behav Med. 2024 Jul-Sep;50(3):260-268. doi: 10.1080/08964289.2023.2249168. Epub 2023 Sep 18.
5
Evaluation of adverse events and comorbidity exacerbation following the COVID-19 booster dose: A national survey among randomly-selected booster recipients.新冠病毒加强针接种后不良事件及合并症加重情况评估:一项针对随机选取的加强针接种者的全国性调查。
PLoS One. 2025 Jul 11;20(7):e0326231. doi: 10.1371/journal.pone.0326231. eCollection 2025.
6
Influences on COVID-19 booster uptake among adults intending to receive a booster: a qualitative study.影响成年人接种 COVID-19 加强针的因素:一项定性研究。
Health Promot Int. 2024 Jun 1;39(3). doi: 10.1093/heapro/daae067.
7
The impact of vaccine booster doses on specific B- and T-lymphocyte dynamics in Thai healthcare personnel following COVID-19 vaccination.新冠疫苗接种后,加强针剂量对泰国医护人员特定B淋巴细胞和T淋巴细胞动态变化的影响
Sci Rep. 2025 Jul 16;15(1):25713. doi: 10.1038/s41598-025-10400-8.
8
Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021.明尼苏达州东南部 19 至 64 岁高危成年人中流感、肺炎球菌和 COVID-19 疫苗接种率的差异,2010-2021 年。
Chest. 2024 Jul;166(1):49-60. doi: 10.1016/j.chest.2024.01.049. Epub 2024 Feb 9.
9
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.在有和没有先前 SARS-CoV-2 感染的人群中,COVID-19 mRNA 疫苗加强针接种后和 COVID-19 后心肌炎和心包炎的风险:在英国的一项自身对照病例系列分析。
PLoS Med. 2023 Jun 7;20(6):e1004245. doi: 10.1371/journal.pmed.1004245. eCollection 2023 Jun.
10
Parental hesitancy on COVID-19 vaccination of children under the age of 16: A cross-sectional mixed-methods study among factory workers.16岁以下儿童新冠疫苗接种的家长犹豫情况:一项针对工厂工人的横断面混合方法研究
PLoS One. 2025 Jun 26;20(6):e0327056. doi: 10.1371/journal.pone.0327056. eCollection 2025.

本文引用的文献

1
Behavioral interventions for vaccination uptake: A systematic review and meta-analysis.接种疫苗行为干预措施:系统评价和荟萃分析。
Health Policy. 2023 Nov;137:104894. doi: 10.1016/j.healthpol.2023.104894. Epub 2023 Sep 4.
2
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.COVID-19 孕期加强疫苗接种可增强母体结合和中和抗体反应,并将抗体转移到新生儿。
Vaccine. 2023 Aug 14;41(36):5296-5303. doi: 10.1016/j.vaccine.2023.06.032. Epub 2023 Jun 13.
3
Accuracy of Self-Reported COVID-19 Vaccination Status Compared With a Public Health Vaccination Registry in Québec: Observational Diagnostic Study.自我报告的 COVID-19 疫苗接种状况与魁北克省公共卫生疫苗接种登记处的准确性比较:观察性诊断研究。
JMIR Public Health Surveill. 2023 Jun 16;9:e44465. doi: 10.2196/44465.
4
Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity.自然免疫和混合免疫个体中与 SARS-CoV-2 再感染相关的结局。
J Infect Public Health. 2023 Aug;16(8):1262-1268. doi: 10.1016/j.jiph.2023.06.003. Epub 2023 Jun 8.
5
Determinants of Covid-19 vaccination: Evidence from the US pulse survey.新冠疫苗接种的决定因素:来自美国脉冲调查的证据。
PLOS Glob Public Health. 2023 May 18;3(5):e0001927. doi: 10.1371/journal.pgph.0001927. eCollection 2023.
6
Evaluation of Waning of SARS-CoV-2 Vaccine-Induced Immunity: A Systematic Review and Meta-analysis.评估 SARS-CoV-2 疫苗诱导免疫的衰减:系统评价和荟萃分析。
JAMA Netw Open. 2023 May 1;6(5):e2310650. doi: 10.1001/jamanetworkopen.2023.10650.
7
Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022.少数民族健康社会脆弱性指数与 COVID-19 疫苗接种覆盖率-美国,2020 年 12 月 14 日-2022 年 1 月 31 日。
Vaccine. 2023 Mar 17;41(12):1943-1950. doi: 10.1016/j.vaccine.2023.02.022. Epub 2023 Feb 13.
8
COVID-19 Mortality and Progress Toward Vaccinating Older Adults - World Health Organization, Worldwide, 2020-2022.COVID-19 死亡率与推进老年人疫苗接种进度-世界卫生组织,全球,2020-2022 年。
MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):113-118. doi: 10.15585/mmwr.mm7205a1.
9
Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022.美国退伍军人在 2020 年 12 月至 2022 年 6 月期间接受 COVID-19 疫苗初级和加强针的比例及其相关因素。
JAMA Netw Open. 2023 Feb 1;6(2):e2254387. doi: 10.1001/jamanetworkopen.2022.54387.
10
A survey of COVID-19 vaccine acceptance across 23 countries in 2022.2022年对23个国家新冠疫苗接受情况的调查。
Nat Med. 2023 Feb;29(2):366-375. doi: 10.1038/s41591-022-02185-4. Epub 2023 Jan 9.

2021年9月至2022年10月在“追踪新冠”队列中完成初级疫苗接种系列的美国成年人首次接种新冠加强针的障碍

Barriers to initial COVID-19 booster among US adults who completed a primary vaccine series in the CHASING COVID cohort, September 2021-October 2022.

作者信息

Rane Madhura S, Shen Yanhan, Robertson Mc Kaylee, Penrose Kate, Srivastava Avantika, Puzniak Laura, Allen Kristen E, Porter Thomas M, Kulkarni Sarah, You William, Berry Amanda, Parcesepe Angela M, Grov Christian, Zimba Rebecca, Nash Denis

机构信息

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, United States.

Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy City University of New York (CUNY), New York, NY, United States.

出版信息

Am J Epidemiol. 2025 May 7;194(5):1341-1351. doi: 10.1093/aje/kwae209.

DOI:10.1093/aje/kwae209
PMID:39013788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12055462/
Abstract

It is crucial to understand factors associated with COVID-19 booster uptake in the United States given the updated COVID-19 vaccine recommendations. Using data from a national prospective cohort (n = 4616) between September 2021 and October 2022, we examined socioeconomic, demographic, and behavioral factors of initial booster uptake among participants fully vaccinated with the primary COVID-19 vaccines series. Cox proportional hazards models were used to estimate the associations of each factor with time to initial booster uptake. Most participants (86.5%) reported receiving their initial booster. After adjusting for age, race/ethnicity, education, region, and employment, participants with greater risk for severe COVID-19 had similar booster uptake compared with those with lower risk (adjusted hazard ratio [aHR], 1.04; 95% CI, 0.95-1.14). Participants with greater barriers to healthcare (aHR, 0.89; 95% CI, 0.84-0.96), food insecurity (aHR, 0.82; 95% CI, 0.75-0.89), and housing instability (aHR, 0.81; 95% CI, 0.73-0.90) were less likely to report receiving initial booster compared with those without those barriers. Factors motivating the decision to vaccinate changed from safety-related concerns for the primary series to perceived need for the booster. It is key to address economic and health access barriers to achieve equitable COVID-19 vaccine uptake and continued protection against COVID-19.

摘要

鉴于最新的新冠病毒疫苗接种建议,了解美国与新冠病毒加强针接种相关的因素至关重要。利用2021年9月至2022年10月期间一个全国性前瞻性队列(n = 4616)的数据,我们研究了已完成新冠病毒主要疫苗系列全程接种的参与者首次接种加强针的社会经济、人口统计学和行为因素。采用Cox比例风险模型来估计每个因素与首次接种加强针时间之间的关联。大多数参与者(86.5%)报告接种了首次加强针。在对年龄、种族/族裔、教育程度、地区和就业情况进行调整后,新冠病毒重症风险较高的参与者与风险较低的参与者相比,加强针接种率相似(调整后风险比[aHR],1.04;95%置信区间[CI],0.95 - 1.14)。与没有这些障碍的参与者相比,医疗保健障碍较大(aHR,0.89;95% CI,0.84 - 0.96)、粮食不安全(aHR,0.82;95% CI,0.75 - 0.89)和住房不稳定(aHR,0.81;95% CI,0.73 - 0.90)的参与者报告接种首次加强针的可能性较小。促使接种疫苗决定的因素从对主要疫苗系列的安全相关担忧转变为对加强针的感知需求。解决经济和健康获取障碍对于实现公平的新冠病毒疫苗接种以及持续预防新冠病毒至关重要。